Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients.

Viviana NocitiMarco BiolatoChiara De FinoAssunta BiancoFrancesco Antonio LosavioMatteo LucchiniGiuseppe MarroneAntonio GriecoMassimiliano Mirabella

Published in: Brain and behavior (2018)

Liver injury after pulsed methylprednisolone therapy in patients with MS is not infrequent, and a close monitoring of aminotransferase level before treatment and 2 weeks later seems advisable.

Keyphrases

liver injury
drug induced
multiple sclerosis
end stage renal disease
high dose
ejection fraction
newly diagnosed
chronic kidney disease
mass spectrometry
prognostic factors
peritoneal dialysis
ms ms
bone marrow
gestational age
patient reported
replacement therapy